
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $46.9B | $54.3B | $57.8B | $59.4B | $59.8B | |
Revenue Growth (YoY) | -10.41% | 15.83% | 6.41% | 2.76% | 0.65% | |
Cost of Revenues | $19.6B | $23.1B | $26.3B | $27.4B | $26.7B | |
Gross Profit | $27.2B | $31.2B | $31.5B | $32B | $33B | |
Gross Profit Margin | 58.12% | 57.47% | 54.48% | 53.86% | 55.25% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $15.4B | $17.6B | $17.6B | $18.2B | $18.3B | |
Other Inc / (Exp) | -$4.5B | -$1.5B | -$1.6B | -$1.1B | -$761M | |
Operating Expenses | $14.6B | $17B | $17B | $17.7B | $17.9B | |
Operating Income | $12.6B | $14.2B | $14.5B | $14.3B | $15.1B | |
Net Interest Expenses | $6B | $4.3B | $3.3B | $4.1B | $3.8B | |
EBT. Incl. Unusual Items | $2.1B | $8.5B | $9.5B | $9.1B | $10.6B | |
Earnings of Discontinued Ops. | $2.1B | -- | -- | -- | -- | |
Income Tax Expense | $1.9B | $2.4B | $1.9B | $2.2B | $3.2B | |
Net Income to Company | $147M | $6.1B | $7.6B | $6.9B | $7.4B | |
Minority Interest in Earnings | -$797M | -$1.4B | -$1.6B | -$1.6B | -$1.6B | |
Net Income to Common Excl Extra Items | $1.4B | $4.7B | $6B | $5.3B | $5.9B | |
Basic EPS (Cont. Ops) | $0.70 | $2.33 | $2.97 | $2.65 | $2.92 | |
Diluted EPS (Cont. Ops) | $0.69 | $2.28 | $2.91 | $2.60 | $2.86 | |
Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
Weighted Average Diluted Share | $2B | $2B | $2.1B | $2.1B | $2B | |
EBITDA | $11.6B | $17.8B | $19B | $19.1B | $20.3B | |
EBIT | $6.7B | $12.7B | $13.9B | $13.7B | $14.8B | |
Revenue (Reported) | $46.9B | $54.3B | $57.8B | $59.4B | $59.8B | |
Operating Income (Reported) | $12.6B | $14.2B | $14.5B | $14.3B | $15.1B | |
Operating Income (Adjusted) | $6.7B | $12.7B | $13.9B | $13.7B | $14.8B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $12.3B | $13.2B | $14.2B | $14.5B | $13.6B | |
Revenue Growth (YoY) | 11.72% | 7.66% | 7.39% | 2.35% | -6.32% | |
Cost of Revenues | $5.2B | $6B | $6.5B | $6.7B | $6B | |
Gross Profit | $7.1B | $7.2B | $7.7B | $7.9B | $7.6B | |
Gross Profit Margin | 57.35% | 54.75% | 54.15% | 54.27% | 55.64% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.1B | $4.1B | $4.3B | $4.4B | $4.2B | |
Other Inc / (Exp) | -$493M | -$1.1B | $379M | -$29M | -$49M | |
Operating Expenses | $3.9B | $4B | $4.2B | $4.3B | $4B | |
Operating Income | $3.1B | $3.3B | $3.5B | $3.6B | $3.6B | |
Net Interest Expenses | $1.2B | $1.2B | $1.2B | -- | $984M | |
EBT. Incl. Unusual Items | $1.4B | $1B | $2.6B | $3.6B | $3.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $529M | $524M | $597M | -- | $664M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$297M | -$404M | -$409M | -$393M | -$396M | |
Net Income to Common Excl Extra Items | $595M | $95M | $1.6B | $1.1B | $2.1B | |
Basic EPS (Cont. Ops) | $0.30 | $0.05 | $0.81 | $0.54 | $1.08 | |
Diluted EPS (Cont. Ops) | $0.30 | $0.05 | $0.81 | $0.54 | $1.08 | |
Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
Weighted Average Diluted Share | $2B | $2B | $2B | $2B | $2B | |
EBITDA | $2.5B | $2B | $3.7B | $3.6B | $3.6B | |
EBIT | $2.5B | $2B | $3.7B | $3.6B | $3.6B | |
Revenue (Reported) | $12.3B | $13.2B | $14.2B | $14.5B | $13.6B | |
Operating Income (Reported) | $3.1B | $3.3B | $3.5B | $3.6B | $3.6B | |
Operating Income (Adjusted) | $2.5B | $2B | $3.7B | $3.6B | $3.6B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $48.2B | $55.2B | $58.8B | $59.7B | $58.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $20.3B | $23.8B | $26.8B | $27.5B | $26.1B | |
Gross Profit | $27.9B | $31.4B | $31.9B | $32.2B | $32.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $15.7B | $17.6B | $17.8B | $18.3B | $18.1B | |
Other Inc / (Exp) | -$3.5B | -$2.3B | $1.2B | -$840M | -$634M | |
Operating Expenses | $15B | $17B | $17B | $17.5B | $17.6B | |
Operating Income | $12.9B | $14.4B | $15B | $14.7B | $15.1B | |
Net Interest Expenses | $3.9B | $4B | $5B | $3.8B | $2.6B | |
EBT. Incl. Unusual Items | $5.4B | $8.1B | $11.2B | $10.1B | $11.8B | |
Earnings of Discontinued Ops. | $1.9B | -- | -- | -- | -- | |
Income Tax Expense | $2.1B | $2.3B | $2B | $2.4B | $3B | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$985M | -$1.6B | -$1.6B | -$1.5B | -$1.6B | |
Net Income to Common Excl Extra Items | $4.3B | $4.2B | $7.5B | $4.8B | $6.9B | |
Basic EPS (Cont. Ops) | $2.13 | $2.08 | $3.72 | $2.38 | $3.45 | |
Diluted EPS (Cont. Ops) | $2.13 | $2.08 | $3.72 | $2.38 | $3.45 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $10.1B | $12.3B | $15.3B | $13.1B | $15.1B | |
EBIT | $10.1B | $12.3B | $15.3B | $13.1B | $15.1B | |
Revenue (Reported) | $48.2B | $55.2B | $58.8B | $59.7B | $58.8B | |
Operating Income (Reported) | $12.9B | $14.4B | $15B | $14.7B | $15.1B | |
Operating Income (Adjusted) | $10.1B | $12.3B | $15.3B | $13.1B | $15.1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $12.3B | $13.2B | $14.2B | $14.5B | $13.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $5.2B | $6B | $6.5B | $6.7B | $6B | |
Gross Profit | $7.1B | $7.2B | $7.7B | $7.9B | $7.6B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $4.1B | $4.1B | $4.3B | $4.4B | $4.2B | |
Other Inc / (Exp) | -$493M | -$1.1B | $379M | -$29M | -$49M | |
Operating Expenses | $3.9B | $4B | $4.2B | $4.3B | $4B | |
Operating Income | $3.1B | $3.3B | $3.5B | $3.6B | $3.6B | |
Net Interest Expenses | $1.2B | $1.2B | $1.2B | -- | $984M | |
EBT. Incl. Unusual Items | $1.4B | $1B | $2.6B | $3.6B | $3.5B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $529M | $524M | $597M | -- | $664M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$297M | -$404M | -$409M | -$393M | -$396M | |
Net Income to Common Excl Extra Items | $595M | $95M | $1.6B | $1.1B | $2.1B | |
Basic EPS (Cont. Ops) | $0.30 | $0.05 | $0.81 | $0.54 | $1.08 | |
Diluted EPS (Cont. Ops) | $0.30 | $0.05 | $0.81 | $0.54 | $1.08 | |
Weighted Average Basic Share | $2B | $2B | $2B | $2B | $2B | |
Weighted Average Diluted Share | $2B | $2B | $2B | $2B | $2B | |
EBITDA | $2.5B | $2B | $3.7B | $3.6B | $3.6B | |
EBIT | $2.5B | $2B | $3.7B | $3.6B | $3.6B | |
Revenue (Reported) | $12.3B | $13.2B | $14.2B | $14.5B | $13.6B | |
Operating Income (Reported) | $3.1B | $3.3B | $3.5B | $3.6B | $3.6B | |
Operating Income (Adjusted) | $2.5B | $2B | $3.7B | $3.6B | $3.6B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $15.3B | $12B | $9.9B | $10.3B | $11.2B | |
Short Term Investments | $396M | $374M | $97M | $67M | $221M | |
Accounts Receivable, Net | $3.3B | $3.5B | $3.6B | $4.3B | $3.8B | |
Inventory | $4.4B | $5.3B | $6.5B | $5.5B | $4.9B | |
Prepaid Expenses | $446M | $465M | $497M | $594M | $572M | |
Other Current Assets | -$1M | $1M | -$1M | -- | -- | |
Total Current Assets | $26.5B | $23.9B | $23.2B | $23.4B | $23B | |
Property Plant And Equipment | $26.4B | $26.7B | $26.7B | $26.8B | $23.5B | |
Long-Term Investments | $6.3B | $6B | $4.8B | $5.1B | $4.8B | |
Goodwill | $121B | $115.8B | $113B | $117B | $110.5B | |
Other Intangibles | $41.5B | $40.4B | $40.2B | $41.3B | $40B | |
Other Long-Term Assets | $184M | $169M | $187M | $164M | $129M | |
Total Assets | $226.4B | $217.6B | $212.9B | $219.3B | $206.6B | |
Accounts Payable | $15.9B | $17.8B | $18.6B | $17.7B | $16B | |
Accrued Expenses | $1.6B | $1.5B | $1.4B | $1.4B | $1.3B | |
Current Portion Of Long-Term Debt | $1.2B | $855M | $399M | $3.1B | $799M | |
Current Portion Of Capital Lease Obligations | $397M | $447M | $529M | $703M | $556M | |
Other Current Liabilities | $5B | $5.8B | $5.3B | $5.3B | $5.8B | |
Total Current Liabilities | $32.4B | $34.2B | $34.4B | $37.2B | $33.1B | |
Long-Term Debt | $93.6B | $85.5B | $76.9B | $72B | $69B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $148.1B | $138.3B | $128.7B | $126.7B | $117.9B | |
Common Stock | $1.7B | $1.7B | $1.7B | $1.7B | $1.7B | |
Other Common Equity Adj | -- | $19.4B | $18.9B | $23.7B | $16.2B | |
Common Equity | $68B | $68.7B | $73.4B | $81.8B | $78.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $10.3B | $10.7B | $10.9B | $10.8B | $10.5B | |
Total Equity | $78.4B | $79.3B | $84.3B | $92.7B | $88.7B | |
Total Liabilities and Equity | $226.4B | $217.6B | $212.9B | $219.3B | $206.6B | |
Cash and Short Terms | $15.6B | $12.4B | $10B | $10.4B | $11.4B | |
Total Debt | $96.3B | $86.6B | $77.5B | $75.3B | $69.9B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | -- | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | -- | -- | -- | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | -- | |
Total Assets | -- | -- | -- | -- | -- | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | -- | -- | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | -- | |
Common Stock | -- | -- | -- | -- | -- | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | -- | |
Total Liabilities and Equity | -- | -- | -- | -- | -- | |
Cash and Short Terms | -- | -- | -- | -- | -- | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $147M | $6.1B | $7.6B | $6.9B | $7.4B | |
Depreciation & Amoritzation | $4.8B | $5.1B | $5.1B | $5.4B | $5.5B | |
Stock-Based Compensation | $169M | $510M | $448M | $570M | $644M | |
Change in Accounts Receivable | $516M | $164M | -$48M | -$1.1B | $341M | |
Change in Inventories | -$427M | -$1.2B | -$1.5B | $717M | -$149M | |
Cash From Operations | $10.9B | $14.8B | $13.3B | $13.3B | $15.1B | |
Capital Expenditures | $3.8B | $5.6B | $5.2B | $4.6B | $3.9B | |
Cash Acquisitions | $10.3B | -$444M | -$70M | $9M | -$46M | |
Cash From Investing | $6.3B | -$5.9B | -$4.3B | -$4.4B | -$3.3B | |
Dividends Paid (Ex Special Dividend) | -$1.8B | -$2.4B | -$2.4B | -$3B | -$2.7B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $14.8B | $454M | $91M | $202M | $5.5B | |
Long-Term Debt Repaid | -$23.6B | -$9.5B | -$7.9B | -$3.9B | -$10.1B | |
Repurchase of Common Stock | -- | -- | -- | -$362M | -$937M | |
Other Financing Activities | $2.1B | -$192M | -$678M | -$1.5B | -$1.6B | |
Cash From Financing | -$8.5B | -$11.6B | -$10.9B | -$8.6B | -$9.9B | |
Beginning Cash (CF) | $7.2B | $15.2B | $12B | $9.9B | $10.3B | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $8.8B | -$2.7B | -$1.9B | $315M | $1.9B | |
Ending Cash (CF) | $15.2B | $12B | $9.9B | $10.3B | $11.2B | |
Levered Free Cash Flow | $7.1B | $9.2B | $8.1B | $8.6B | $11.2B |
Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3.7B | $3.1B | $2.5B | $2.7B | $3.2B | |
Depreciation & Amoritzation | $2.4B | $2.4B | $2.5B | $2.6B | $2.7B | |
Stock-Based Compensation | -$18M | $345M | $237M | $286M | $315M | |
Change in Accounts Receivable | $15M | -$755M | -$581M | -$1.3B | -$1.2B | |
Change in Inventories | -$487M | -$894M | -$833M | -$228M | -$325M | |
Cash From Operations | $1.1B | $3.9B | $2.2B | $1.6B | $2.6B | |
Capital Expenditures | $1.6B | $2.2B | $2B | $2.1B | $1.7B | |
Cash Acquisitions | $10.6B | -$203M | -$44M | -$8M | -$19M | |
Cash From Investing | $9.1B | -$2.2B | -$1.9B | -$2.1B | -$1.7B | |
Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.4B | -$1.3B | -$1.9B | -$2.1B | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $14.5B | $370M | $68M | $181M | $5.5B | |
Long-Term Debt Repaid | -$4.6B | -$8.6B | -$3.8B | -$385M | -$4.7B | |
Repurchase of Common Stock | -- | -- | -- | -- | -$838M | |
Other Financing Activities | -$458M | -$470M | -$378M | -$668M | -$1.1B | |
Cash From Financing | $8.2B | -$10.1B | -$5.4B | -$2.8B | -$3.3B | |
Beginning Cash (CF) | $7.2B | $15.2B | $12B | $9.9B | $10.3B | |
Foreign Exchange Rate Adjustment | -$720M | -$126M | -$18M | $191M | -$463M | |
Additions / Reductions | $18.4B | -$8.4B | -$5.1B | -$3.3B | -$2.5B | |
Ending Cash (CF) | $24.9B | $6.7B | $6.9B | $6.8B | $7.4B | |
Levered Free Cash Flow | -$461M | $1.8B | $180M | -$510M | $833M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -$18M | $345M | $237M | $286M | $315M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | $1.6B | $2.2B | $2B | $2.1B | $1.7B | |
Cash Acquisitions | $10.6B | -$203M | -$44M | -$8M | -$19M | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -$1.2B | -$1.4B | -$1.3B | -$1.9B | -$2.1B | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $3.1B | $2.5B | $2.7B | $3.2B | -- | |
Depreciation & Amoritzation | $2.4B | $2.5B | $2.6B | $2.7B | -- | |
Stock-Based Compensation | $345M | $237M | $286M | $315M | -- | |
Change in Accounts Receivable | -$755M | -$581M | -$1.3B | -$1.2B | -- | |
Change in Inventories | -$894M | -$833M | -$228M | -$325M | -- | |
Cash From Operations | $3.9B | $2.2B | $1.6B | $2.6B | -- | |
Capital Expenditures | $2.2B | $2B | $2.1B | $1.7B | -- | |
Cash Acquisitions | -$203M | -$44M | -$8M | -$19M | -- | |
Cash From Investing | -$2.2B | -$1.9B | -$2.1B | -$1.7B | -- | |
Dividends Paid (Ex Special Dividend) | -$1.4B | -$1.3B | -$1.9B | -$2.1B | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $370M | $68M | $181M | $5.5B | -- | |
Long-Term Debt Repaid | -$8.6B | -$3.8B | -$385M | -$4.7B | -- | |
Repurchase of Common Stock | -- | -- | -- | -$838M | -- | |
Other Financing Activities | -$470M | -$378M | -$668M | -$1.1B | -- | |
Cash From Financing | -$10.1B | -$5.4B | -$2.8B | -$3.3B | -- | |
Beginning Cash (CF) | $15.2B | $12B | $9.9B | $10.3B | -- | |
Foreign Exchange Rate Adjustment | -$126M | -$18M | $191M | -$463M | -- | |
Additions / Reductions | -$8.4B | -$5.1B | -$3.3B | -$2.5B | -- | |
Ending Cash (CF) | $6.7B | $6.9B | $6.8B | $7.4B | -- | |
Levered Free Cash Flow | $1.8B | $180M | -$510M | $833M | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.